Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ

NCT02694809 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02694809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02694809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
June 19, 2024
Enrollment
142 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, postmenopausal